Becton, Dickinson and Company Common Stock

Financials

Genel Bakış Tablolar İstatistikler Temettüler

İşletme faaliyetlerinden elde edilen nakit 3.54 B4.65 B2.63 B2.99 B3.8 B3.43 B 4.75 B Yatırım faaliyetlerinden elde edilen nakit -1.23 B-1.88 B-3.23 B-716 M-5.51 B-818 M -1.15 B Finansman faaliyetlerinden elde edilen nakit 22 M-3.31 B-591 M-1.96 B2.09 B-3.62 B -6.22 B Serbest nakit akışı 3.54 B4.65 B1.66 B2.12 B3.07 B2.67 B 4.1 B

Becton, Dickinson and Company is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain areas. BD is ranked #211 in the 2024 Fortune 500 list based on its revenues for the fiscal year ending September 30, 2023.

BDX

Financials

Becton, Dickinson and Company Common Stock

Haberler

How Abbott's Diagnostics Unit Is Shaping Up Through the Rest of 2026

Best Dividend Aristocrats: May 2026

Best Dividend Kings: May 2026

BD Launches Elyra Thulium Fiber Laser System for Kidney Stone Care

Çin 50’den fazla yabancı ilaç firmasıyla yuvarlak masa toplantısı düzenledi

BD böbrek taşı prosedürleri için Elyra lazer sistemini piyasaya sürdü

Becton Dickinson’ın yan kuruluşu 2033 vadeli 600 milyon euro tahvil ihraç etti

Top Stock Gainers Today, 5/19/26 - TipRanks.com

Is Wall Street Bullish or Bearish on Becton, Dickinson and Company Stock?

BD müdahale birimi başkanlığına Peter Menziuso’yu atadı

Becton, Dickinson and Company (BDX) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Boston Scientific: Poised To Rebound With The Healthcare Sector, But When? (NYSE:BSX)